BioSimilar FDA Accepts Apotex’s Neupogen Biosimilar Application: Raises Issues… Thomas Sullivan Feb 19, 2015 2 Apotex Inc. has announced that as of February 13, 2015, the FDA has accepted for filing the company's application for filgrastim,…
